Browse All

Current Filters

CLEAR FILTER x

TITLE

Real-world Tolerability, Safety, and Effectiveness of Ofatumumab in Adults With Multiple Sclerosis Over 36 Months

Author:Arias, Diana   Musser, Leah   Carrabe, Kailey   Du, Mengke   Conway, Devon   Amin, Moein   Hersh, Carrie   

Session Name:P4: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 4  

Topic:Multiple Sclerosis  

Program Number:P4.002  

Author Institution:Cleveland Clinic Foundation, Aurora, OH  Cleveland Clinic Foundation, Westlake, OH  Touro University, NV  Cleveland Clinic, Cleveland, OH  Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV  

Real-world Experience With Ozanimod at Two Academic Multiple Sclerosis Centers With Expanded 24-month Data

Author:Conway, Devon   Cooperrider, Jessica   Lambe, Jeffrey   Du, Mengke   Chu, Michelle   Gatza, Michael   Cusack, Corey   Takere Abam, Jacqueline   Reardon, Jennifer   Chaudhry, Burhan   Schroedle, Christina   Hersh, Carrie   

Session Name:P4: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 4  

Topic:Multiple Sclerosis  

Program Number:P4.003  

Author Institution:Cleveland Clinic, Cleveland, OH  Cleveland Clinic, University Heights, OH  Oregon Health and Science University, OR  BMS, Lawrence Township, NJ  BMS, NJ  BMS, St. Louis, MO  Marian University, IN  Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV  

Real Life Effectiveness and Tolerability of Cladribine Tablets (CladT) after Five Years of Treatment

Author:Pato Pato, Antonio   Lorenzo González, José Ramón   García Estévez, Daniel Apolinar   López Real, Ana María   Rodriguez Regal, Ana   Costa Arpin, Eva   Rodriguez Rodriguez, María   Alvarez Rodriguez, Elena   Alberte Woodgard, Miguel   Aguado Valcarcel, Marta   González Suarez, Inés   Prieto Gonzalez, José María Oscar   

Session Name:P4: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 4  

Topic:Multiple Sclerosis  

Program Number:P4.004  

Author Institution:Complexo Hospitalario de Vigo, Vigo, Spain  Hospital Povisa de Vigo, Vigo, Spain  Complexo Hospitalario de Ourense, Ourense, Spain  Complexo Hospitalario de A Coruña, A Coruña, Spain  Complexo Hospitalario de Pontevedra, Pontevedra, Spain  Complexo Hospitalario de Ferrol, Ferrol, Spain  Hospital Universitario Lucus Augusti, Lugo, Spain  Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain  

Reducing the Risk of PIRA in RRMS: The Value of High-efficacy Disease- Modifying Therapies

Author:Guarnaschelli, Maria Flor   Marrodan, Mariano   Sosa, Braian   Perez Arana, Carolina   Farez, Mauricio   Fiol, Marcela   Celica, Ysrraelit   Correale, Jorge   

Session Name:P4: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 4  

Topic:Multiple Sclerosis  

Program Number:P4.005  

Author Institution:FLENI, City of Buenos Aires, Argentina  Institute for Neurological Research, Buenos Aires, Argentina  

A Community-driven, Data-informed Health Literacy Intervention for Multiple Sclerosis: Findings From a Pilot Awareness Campaign

Author:Rivera, Yahaira   

Session Name:P4: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 4  

Topic:Multiple Sclerosis  

Program Number:P4.006  

Author Institution:Multiple Sclerosis Association of America, Cherry Hill, NJ